Karima Yakouben
Overview
Explore the profile of Karima Yakouben including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
726
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dourthe M, Yakouben K, David A, Thouvenin S, Chaillou D, Caillat-Zucman S, et al.
Br J Haematol
. 2024 May;
205(1):373-377.
PMID: 38735758
No abstract available.
2.
Vasseur L, Cuffel A, Pondarre C, Dalle J, Chevillon F, Fourmont A, et al.
Bone Marrow Transplant
. 2024 Feb;
59(5):708-710.
PMID: 38413822
No abstract available.
3.
Missontsa M, Bernaudin F, Fortin A, Dhedin N, Pondarre C, Yakouben K, et al.
J Assist Reprod Genet
. 2024 Feb;
41(4):1027-1034.
PMID: 38358434
Purpose: To describe the experience of performing ovarian tissue cryopreservation (OTC) before hematopoietic stem cell transplantation (HSCT), among girls/women with severe sickle cell disease (SCD)(SS or S/β-thalassemia) who are, besides...
4.
Rossi M, Szepetowski S, Yakouben K, Paillard C, Sirvent A, Castelle M, et al.
Bone Marrow Transplant
. 2023 Aug;
58(11):1254-1256.
PMID: 37542188
No abstract available.
5.
Barraud-Lange V, Boissel N, Gille A, Jean C, Sitbon L, Schubert B, et al.
Andrology
. 2023 Jul;
12(2):385-395.
PMID: 37418281
Background: A growing number of centers worldwide are preserving testicular tissue (TT) of young boys at risk of fertility loss to preserve their fertility. Data in this regard are scarce...
6.
Delafoy M, Goutines J, Fourmont A, Birgy A, Chomton M, Levy M, et al.
Front Oncol
. 2022 Jul;
12:912695.
PMID: 35875088
Background: Hyperammonemic encephalopathy caused by spp. and infection has been reported in immunocompromised patients undergoing lung transplant, but data are scarce in patients with hematological malignancies. Case Presentation: We describe...
7.
Beauvais D, Castilla-Llorente C, Diral E, Sirvent A, Vandewiele A, Baruchel A, et al.
Bull Cancer
. 2022 Jul;
110(2S):S108-S115.
PMID: 35791974
The role of allogeneic hematopoietic cell transplantation (allo-HCT) after CAR T- treatment cells in hematologic malignancies is currently controversial. Prolonged remissions after several years of follow-up suggest that there is...
8.
Calvo C, Lainey E, Caye A, Cuccuini W, Fenneteau O, Yakouben K, et al.
Br J Haematol
. 2022 Jun;
198(6):1069-1072.
PMID: 35732340
No abstract available.
9.
Dourthe M, Rabian F, Yakouben K, Chevillon F, Cabannes-Hamy A, Mechinaud F, et al.
Leukemia
. 2021 May;
35(12):3383-3393.
PMID: 34002027
Tisagenlecleucel therapy has shown promising efficacy for relapsed/refractory (R/R) B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, relapses occur in 30-50% of patients. Determinants for CD19 versus CD19 relapses are poorly...
10.
Brethon B, Lainey E, Caye-Eude A, Grain A, Fenneteau O, Yakouben K, et al.
Front Oncol
. 2021 Mar;
11:637951.
PMID: 33718232
Mixed phenotype acute leukemia (MPAL) accounts for 2-5% of leukemia in children. MPAL are at higher risk of induction failure. Lineage switch (B to M or vice versa) or persistence...